Biotech’s coming of age
Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sector’s contours www.nature.com/articles/s41...
Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sector’s contours.